Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad R Ritch

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
European Urology Focus|May 20, 2019
Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder CancerShuo-Chieh Wu, Deukwoo Kwon, Joshua S Jue, et al.
The Journal of Urology|September 9, 2014
Increasing use of observation among men at low risk for prostate cancer mortalityChad R Ritch, Amy J Graves, Kirk A Keegan, et al.
Urology|April 10, 2018
The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality After Radical Prostatectomy in Hispanic or Latino Men: A Population-based AnalysisMaria C Velasquez, Felix M Chinea, Deukwoo Kwon, et al.
BJU International|December 28, 2017
Racial disparity and survival outcomes between African-American and Caucasian American men with penile cancerChad R Ritch, Nachiketh Soodana-Prakash, Nicola Pavan, et al.
Urologic Oncology|August 18, 2019
Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancerFelix V Chen, Tulay Koru-Sengul, Feng Miao, et al.
Urology|August 27, 2017
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility CriteriaBruno Nahar, Andrew Katims, Marcelo Panizzutti Barboza, et al.
World Journal of Urology|March 12, 2025
Use of biochemical and imaging criteria for selecting patients for prostate biopsy in recurrence risk assessment post-HIFU therapyTarek Ajami, Adam Williams, Jonathan T Ryan, et al.
Urologic Oncology|December 23, 2019
Timing of adjuvant chemotherapy and overall survival following radical cystectomyJoshua S Jue, Tulay Koru-Sengul, Feng Miao, et al.
BJUI Compass|August 19, 2024
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant TherapyTarek Ajami, Sunwoo Han, Ruben Blachman-Braun, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
European Urology Focus|May 20, 2019
Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder CancerShuo-Chieh Wu, Deukwoo Kwon, Joshua S Jue, et al.
The Journal of Urology|September 9, 2014
Increasing use of observation among men at low risk for prostate cancer mortalityChad R Ritch, Amy J Graves, Kirk A Keegan, et al.
Urology|April 10, 2018
The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality After Radical Prostatectomy in Hispanic or Latino Men: A Population-based AnalysisMaria C Velasquez, Felix M Chinea, Deukwoo Kwon, et al.
BJU International|December 28, 2017
Racial disparity and survival outcomes between African-American and Caucasian American men with penile cancerChad R Ritch, Nachiketh Soodana-Prakash, Nicola Pavan, et al.
Urologic Oncology|August 18, 2019
Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancerFelix V Chen, Tulay Koru-Sengul, Feng Miao, et al.
Urology|August 27, 2017
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility CriteriaBruno Nahar, Andrew Katims, Marcelo Panizzutti Barboza, et al.
World Journal of Urology|March 12, 2025
Use of biochemical and imaging criteria for selecting patients for prostate biopsy in recurrence risk assessment post-HIFU therapyTarek Ajami, Adam Williams, Jonathan T Ryan, et al.
Urologic Oncology|December 23, 2019
Timing of adjuvant chemotherapy and overall survival following radical cystectomyJoshua S Jue, Tulay Koru-Sengul, Feng Miao, et al.
BJUI Compass|August 19, 2024
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant TherapyTarek Ajami, Sunwoo Han, Ruben Blachman-Braun, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
Pageof 9